Skip to Main Content

Author Details

Jochen K Lennerz
Massachusetts General Hospital/Harvard Medical School
2004
241
51
Nevan J Krogan (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37556776Compromised Outcomes in Stage IV Non-Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data.JCO Oncol Pract2024
36288512Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic <i>NF2</i> Mutations.J Clin Oncol2023
37808694Germline mutations and developmental mosaicism underlying <i>EGFR</i>-mutant lung cancer.medRxiv2023
37561981The Cholangiocarcinoma in the Young (CITY) Study: Tumor Biology, Treatment Patterns, and Survival Outcomes in Adolescent Young Adults With Cholangiocarcinoma.JCO Precis Oncol2023
37580849Computational pathology in cancer diagnosis, prognosis, and prediction - present day and prospects.J Pathol2023
37686115Exploring the Skin Brain Link: Biomarkers in the Skin with Implications for Aging Research and Alzheimer's Disease Diagnostics.Int J Mol Sci2023
37608772Pitfalls in machine learning-based assessment of tumor-infiltrating lymphocytes in breast cancer: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerJ Pathol2023
37608771Spatial analyses of immune cell infiltration in cancer: current methods and future directions: A report of the International Immuno-Oncology Biomarker Working Group on Breast Cancer.J Pathol2023
37533439Efficacy and Tolerability of <i>ALK</i>/<i>MET</i> Combinations in Patients With <i>ALK</i>-Rearranged Lung Cancer With Acquired <i>MET</i> Amplification: A Retrospective Analysis.JTO Clin Res Rep2023
37813016Molecular heterogeneity and co-altered genes in MET-amplified ALK-positive lung cancer: Implications for MET targeted therapy.Lung Cancer2023
37390098Prognostic biomarkers for survival in mucosal melanoma.Pigment Cell Melanoma Res2023
37256085Sustainable development goals applied to digital pathology and artificial intelligence applications in low- to middle-income countries.Front Med (Lausanne)2023
37079044Where is laboratory medicine headed in the next decade? Partnership model for efficient integration and adoption of artificial intelligence into medical laboratories.Clin Chem Lab Med2023
37440641Recruited macrophages elicit atrial fibrillation.Science2023
37040087Molecular profiling and treatment pattern differences between intrahepatic and extrahepatic cholangiocarcinoma.J Natl Cancer Inst2023
37301916Bayesian risk prediction model for colorectal cancer mortality through integration of clinicopathologic and genomic data.NPJ Precis Oncol2023
37461736Harmonized cross-species cell atlases of trigeminal and dorsal root ganglia.bioRxiv2023
36696602Diagnostic quality model (DQM): an integrated framework for the assessment of diagnostic quality when using AI/ML.Clin Chem Lab Med2023
36882240Geographically skewed recruitment and COVID-19 seroprevalence estimates: a cross-sectional serosurveillance study and mathematical modelling analysis.BMJ Open2023
36852573Real-world data for precision cancer medicine-A European perspective.Genes Chromosomes Cancer2023
36812363Clinical Next-Generation Sequencing Panels Reveal Molecular Differences Between Merkel Cell Polyomavirus-Negative Merkel Cell Carcinomas and Neuroendocrine Carcinomas.Am J Clin Pathol2023
36743521TRK inhibitor in a patient with metastatic triple-negative breast cancer and <i>NTRK</i> fusions identified <i>via</i> cell-free DNA analysis.Ther Adv Med Oncol2023
36801639Slide-to-Slide Tissue Transfer and Array Assembly From Limited Samples for Comprehensive Molecular Profiling.Lab Invest2023
36603288Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decade.EBioMedicine2023
36493359Clinical Implications and Treatment Strategies for ESR1 Fusions in Hormone Receptor-Positive Metastatic Breast Cancer: A Case Series.Oncologist2023
34726838Next-generation sequencing in the evaluation of biliary strictures in patients with primary sclerosing cholangitis.Cancer Cytopathol2022
35349784Human and mouse trigeminal ganglia cell atlas implicates multiple cell types in migraine.Neuron2022
35704798Molecular Characterization of Mesothelioma: Impact of Histologic Type and Site of Origin on Molecular Landscape.JCO Precis Oncol2022
35852437Implementation and Clinical Adoption of Precision Oncology Workflows Across a Healthcare Network.Oncologist2022
35595518Partial Postponement of the Application of the In Vitro Diagnostic Medical Devices Regulation in the European Union.Clin Chem2022
35457138Diagnostic Value of MAML2 Rearrangements in Mucoepidermoid Carcinoma.Int J Mol Sci2022
35622910Development of oil-based gels as versatile drug delivery systems for pediatric applications.Sci Adv2022
36555474Protein-Based Oncopanel as Addition to Target Sequencing in Head and Neck Squamous Cell Carcinoma to Individualize Treatment Decisions.Int J Mol Sci2022
36437503Prognostic role of inflammatory diets in colorectal cancer overall and in strata of tumor-infiltrating lymphocyte levels.Clin Transl Med2022
35871081Mucoepidermoid carcinoma (MEC) and adenosquamous carcinoma (ASC), the same or different entities?Mod Pathol2022
35871080Identification of fusions with potential clinical significance in melanoma.Mod Pathol2022
36178347Primary Thyroid Neoplasm with Fetal Morphology Associated with <i>DICER1</i> Mutations: Expanding the Diagnostic Profile of Thyroblastoma.Thyroid2022
36041084Developmental Deconvolution for Classification of Cancer Origin.Cancer Discov2022
36137393Selecting patients with HER2-low breast cancer: Getting out of the tangle.Eur J Cancer2022
36103364Profile and Predictors of Blood Tumor Mutational Burden in Advanced Hepatocellular Carcinoma.Oncologist2022
35995898Highdicom: a Python Library for Standardized Encoding of Image Annotations and Machine Learning Model Outputs in Pathology and Radiology.J Digit Imaging2022
36170378RoboCap: Robotic mucus-clearing capsule for enhanced drug delivery in the gastrointestinal tract.Sci Robot2022
36327445Where is laboratory medicine headed in the next decade? Partnership model for efficient integration and adoption of artificial intelligence into medical laboratories.Clin Chem Lab Med2022
36266514Ensuring remote diagnostics for pathologists: an open letter to the US Congress.Nat Med2022
36380011A unifying force for the realization of medical AI.NPJ Digit Med2022
36089135The clinical landscape of cell-free DNA alterations in 1671 patients with advanced biliary tract cancer.Ann Oncol2022
36118132Clinicopathologic Characteristics and Outcomes for Patients With <i>KRAS</i> G12D-Mutant NSCLC.JTO Clin Res Rep2022
36190545FGFR mRNA Expression in Cholangiocarcinoma and Its Correlation with FGFR2 Fusion Status and Immune Signatures.Clin Cancer Res2022
33631297Artificial intelligence and pathology: From principles to practice and future applications in histomorphology and molecular profiling.Semin Cancer Biol2022
34857594Cell-Free HPV DNA Provides an Accurate and Rapid Diagnosis of HPV-Associated Head and Neck Cancer.Clin Cancer Res2022
  • 1 - 50 of 241

Recommended Authors

Monash University
Career Start Year 2016
Number of shared co-authors 0
H. Lee Moffitt Cancer Center and Research Institute
Career Start Year 2013
Number of shared co-authors 1
Weill Cornell Medicine and New York Presbyterian Hospital
Career Start Year 2013
Number of shared co-authors 0
Oregon State University
Career Start Year 2011
Number of shared co-authors 1
Curie Institute Hospital Group
Career Start Year 2008
Number of shared co-authors 2
Emory School of Medicine
Career Start Year 2008
Number of shared co-authors 11
University of California los angeles
Career Start Year 2008
Number of shared co-authors 1
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2008
Number of shared co-authors 4
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Career Start Year 2007
Number of shared co-authors 1
University of Cincinnati College of Medicine
Career Start Year 2007
Number of shared co-authors 8
The University of Texas M. D. Anderson
Career Start Year 2006
Number of shared co-authors 5
Washington University
Career Start Year 2003
Number of shared co-authors 9
Memorial Sloan Kettering Cancer Center
Career Start Year 2003
Number of shared co-authors 9
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 3
Institute of Pathology, University Hospital Heidelberg
Career Start Year 2002
Number of shared co-authors 11
Caryl and Israel Englander Institute for Precision Medicine
Career Start Year 2002
Number of shared co-authors 13
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 15
Institut fur Pathologie, Universitatsmedizin Mannheim
Career Start Year 2000
Number of shared co-authors 9
Western University
Career Start Year 1999
Number of shared co-authors 2
The University of Texas MD Anderson Cancer Center
Career Start Year 1999
Number of shared co-authors 5
Northwestern University Feinberg School of Medicine
Career Start Year 1998
Number of shared co-authors 1
Walter Reed National Military Medical Center
Career Start Year 1997
Number of shared co-authors 3
Stanford University
Career Start Year 1996
Number of shared co-authors 0
Center for Cancer Research, National Cancer Institute
Career Start Year 1994
Number of shared co-authors 3
Jonsson Comprehensive Cancer Center, University of California los angeles
Career Start Year 1992
Number of shared co-authors 3
University of Texas MD Anderson Cancer Center
Career Start Year 1989
Number of shared co-authors 2
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 5
Perelman School of Medicine, University of Pennsylvania, USA Abramson Cancer Center
Career Start Year 1986
Number of shared co-authors 10
Oregon Health & Science University
Career Start Year 1985
Number of shared co-authors 11
Queen's University
Career Start Year 1982
Number of shared co-authors 7

Collaborators

Massachusetts General Hospital
Co-authored papers 51
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 19
Co-authored papers 18
Massachusetts General Hospital, USA Harvard Medical School
Co-authored papers 15
Massachusetts General Hospital Cancer Center, Harvard Medical School
Co-authored papers 13
Co-authored papers 9
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Co-authored papers 8
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 7
Massachusetts General Hospital Cancer Center
Co-authored papers 7
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 6
Co-authored papers 6
Massachusetts General Hospital
Co-authored papers 5
Co-authored papers 5
Ragon Institute of MGH
Co-authored papers 5
Institute of Pathology, Charite Universitatsmedizin Berlin
Co-authored papers 5
Co-authored papers 5
Massachusetts General Hospital
Co-authored papers 5
Broad Institute of the Massachusetts Institute of Technology and Harvard
Co-authored papers 5
Co-authored papers 5
Massachusetts General Hospital
Co-authored papers 5
Co-authored papers 5
University of California san francisco
Co-authored papers 4
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 4
Brigham and Women's Hospital
Co-authored papers 4
Massachusetts General Hospital
Co-authored papers 4
Massachusetts General Hospital
Co-authored papers 4
Guardant Health Inc.
Co-authored papers 4
Foundation Medicine
Co-authored papers 3
Broad Institute of Massachusetts Institute of Technology and Harvard
Co-authored papers 3
Institute of Pathology, University Hospital Heidelberg
Co-authored papers 3